MedTrace Logo

A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma

NCT05547074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2022-09-22

No results posted yet for this study

Summary

The AJCC TNM staging system is the prevailing method in prognostic evaluation of pancreatic ductal adenocarcinoma (PDAC) at present , but it did not include factors such as the tumor immune microenvironment that are known to exert a profound impact on patients'clinical outcome. This study was aimed to develop a comprehensive and effective prognostic score model to predict prognosis and guide clinical management for postoperative PDAC patients.

Conditions

  • Neoplasms Pancreatic

Interventions

PROCEDURE

pancreatic cancer surgery

Surgical resection of pancreatic cancer，including radical or palliative surgery

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Tingbo Liang · First Affiliated Hospital, Medical College of Zhejiang University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-10-30
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05547074 on ClinicalTrials.gov